Cargando…

Genetic polymorphism and transcriptional regulation of CREBBP gene in patient with diffuse large B-cell lymphoma

In the present study, we aim to examine the relationship between genetic polymorphism and transcriptional expression of cyclic AMP response element binding protein (CREBBP) and the risk of diffuse large B-cell lymphoma (DLBCL). Two hundred and fifty healthy individuals and 248 DLBCL patients partici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Haifeng, Kan, Yutian, Wang, Xinyuan, Chen, Leiyuan, Ge, Peng, Qian, Zhengzi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692565/ https://www.ncbi.nlm.nih.gov/pubmed/31366566 http://dx.doi.org/10.1042/BSR20191162

Ejemplares similares

Overexpression of microRNA-130a predicts adverse prognosis of primary gastrointestinal diffuse large B-cell lymphoma
por: Chen, Leiyuan, et al.
Publicado: (2020)

miR-150 is a negative independent prognostic biomarker for primary gastrointestinal diffuse large B-cell lymphoma
por: Wang, Xinyuan, et al.
Publicado: (2020)

SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population
por: Kan, Yutian, et al.
Publicado: (2018)

Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma
por: Nie, Man, et al.
Publicado: (2021)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
por: Juskevicius, Darius, et al.
Publicado: (2017)

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma
por: Wu, Zizheng, et al.
Publicado: (2021)

PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma
por: Zhang, Huilai, et al.
Publicado: (2022)

JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma
por: Schuhmacher, Bianca, et al.
Publicado: (2019)

Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
por: Qu, Zhenjie, et al.
Publicado: (2022)

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
por: Huang, Yao-Hui, et al.
Publicado: (2021)

Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma
por: Zhang, Tingting, et al.
Publicado: (2020)

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
por: Shen, Rong, et al.
Publicado: (2023)

CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia
por: Fluhr, Silvia, et al.
Publicado: (2016)

Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma”
por: Zhang, Tingting, et al.
Publicado: (2021)

Early progression and transformation of a splenic diffuse red pulp small B-cell lymphoma with NOTCH1, ARID2, CREBBP, and TNFRSF14 gene mutations
por: Lopedote, Paolo, et al.
Publicado: (2023)

Genetic and epigenetic determinants of diffuse large B-cell lymphoma
por: Bakhshi, Tanner J., et al.
Publicado: (2020)

Massive Transcriptional Perturbation in Subgroups of Diffuse Large B-Cell Lymphomas
por: Rosolowski, Maciej, et al.
Publicado: (2013)

Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients
por: Fei, Yue, et al.
Publicado: (2020)

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014)

Genetic Profiling in Diffuse Large B Cell Lymphoma – the promise and the challenge
por: Cutmore, Natasha H., et al.
Publicado: (2023)

Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
por: Leveille, Etienne, et al.
Publicado: (2021)

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma
por: Bernatsky, Sasha, et al.
Publicado: (2017)

Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma
por: Tong, Yong, et al.
Publicado: (2018)

CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma
por: Xian, Rena R., et al.
Publicado: (2020)

Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019)

Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma
por: Ge, Xueling, et al.
Publicado: (2012)

The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)

Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma
por: Wang, Huan-You, et al.
Publicado: (2021)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients
por: Bentivegna, Angela, et al.
Publicado: (2006)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
por: Pisapia, David J., et al.
Publicado: (2020)

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2018)

CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300 mutated lymphomas
por: Veazey, Kylee J., et al.
Publicado: (2020)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1m1anksbrpkeel5769mir2ctep